Medical Devices & Consumables
Global Drug or Substance Abuse Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 607052
- Pages: 132
- Figures: 143
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Drug or Substance Abuse Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
Thermo Fisher
Roche
Siemens Healthineers
Wondfo Biotech
Randox
OraSure
Draeger
InTec
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Segment by Type
Urine Testing
Saliva Testing
Blood Testing
Hair and Sweat Testing
Others
Segment by Application
Hospital
Law Enforcement
Drug Treatment Center
Laboratory
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Drug or Substance Abuse Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Drug or Substance Abuse Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
Thermo Fisher
Roche
Siemens Healthineers
Wondfo Biotech
Randox
OraSure
Draeger
InTec
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Segment by Type
Urine Testing
Saliva Testing
Blood Testing
Hair and Sweat Testing
Others
Segment by Application
Hospital
Law Enforcement
Drug Treatment Center
Laboratory
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Drug or Substance Abuse Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Drug or Substance Abuse Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Drug or Substance Abuse Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Urine Testing
1.2.3 Saliva Testing
1.2.4 Blood Testing
1.2.5 Hair and Sweat Testing
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Drug or Substance Abuse Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Law Enforcement
1.3.4 Drug Treatment Center
1.3.5 Laboratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug or Substance Abuse Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Drug or Substance Abuse Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Drug or Substance Abuse Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Drug or Substance Abuse Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Urine Testing Market Size by Players
3.3.2 Saliva Testing Market Size by Players
3.3.3 Blood Testing Market Size by Players
3.3.4 Hair and Sweat Testing Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Drug or Substance Abuse Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Drug or Substance Abuse Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Drug or Substance Abuse Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Drug or Substance Abuse Testing Market Size by Type (2020-2031)
6.4 North America Drug or Substance Abuse Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Drug or Substance Abuse Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Drug or Substance Abuse Testing Market Size by Type (2020-2031)
7.4 Europe Drug or Substance Abuse Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Drug or Substance Abuse Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Drug or Substance Abuse Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Drug or Substance Abuse Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Drug or Substance Abuse Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Drug or Substance Abuse Testing Market Size by Type (2020-2031)
9.4 Central and South America Drug or Substance Abuse Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Drug or Substance Abuse Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Drug or Substance Abuse Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Drug or Substance Abuse Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Drug or Substance Abuse Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Drug or Substance Abuse Testing Product Features and Attributes
11.1.4 Abbott Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Drug or Substance Abuse Testing Revenue by Product in 2024
11.1.6 Abbott Drug or Substance Abuse Testing Revenue by Application in 2024
11.1.7 Abbott Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.1.8 Abbott Drug or Substance Abuse Testing SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Corporation Information
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Drug or Substance Abuse Testing Product Features and Attributes
11.2.4 Thermo Fisher Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Drug or Substance Abuse Testing Revenue by Product in 2024
11.2.6 Thermo Fisher Drug or Substance Abuse Testing Revenue by Application in 2024
11.2.7 Thermo Fisher Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Drug or Substance Abuse Testing SWOT Analysis
11.2.9 Thermo Fisher Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Drug or Substance Abuse Testing Product Features and Attributes
11.3.4 Roche Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.3.5 Roche Drug or Substance Abuse Testing Revenue by Product in 2024
11.3.6 Roche Drug or Substance Abuse Testing Revenue by Application in 2024
11.3.7 Roche Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.3.8 Roche Drug or Substance Abuse Testing SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Corporation Information
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Drug or Substance Abuse Testing Product Features and Attributes
11.4.4 Siemens Healthineers Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.4.5 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Product in 2024
11.4.6 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Application in 2024
11.4.7 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.4.8 Siemens Healthineers Drug or Substance Abuse Testing SWOT Analysis
11.4.9 Siemens Healthineers Recent Developments
11.5 Wondfo Biotech
11.5.1 Wondfo Biotech Corporation Information
11.5.2 Wondfo Biotech Business Overview
11.5.3 Wondfo Biotech Drug or Substance Abuse Testing Product Features and Attributes
11.5.4 Wondfo Biotech Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.5.5 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Product in 2024
11.5.6 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Application in 2024
11.5.7 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.5.8 Wondfo Biotech Drug or Substance Abuse Testing SWOT Analysis
11.5.9 Wondfo Biotech Recent Developments
11.6 Randox
11.6.1 Randox Corporation Information
11.6.2 Randox Business Overview
11.6.3 Randox Drug or Substance Abuse Testing Product Features and Attributes
11.6.4 Randox Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.6.5 Randox Recent Developments
11.7 OraSure
11.7.1 OraSure Corporation Information
11.7.2 OraSure Business Overview
11.7.3 OraSure Drug or Substance Abuse Testing Product Features and Attributes
11.7.4 OraSure Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.7.5 OraSure Recent Developments
11.8 Draeger
11.8.1 Draeger Corporation Information
11.8.2 Draeger Business Overview
11.8.3 Draeger Drug or Substance Abuse Testing Product Features and Attributes
11.8.4 Draeger Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.8.5 Draeger Recent Developments
11.9 InTec
11.9.1 InTec Corporation Information
11.9.2 InTec Business Overview
11.9.3 InTec Drug or Substance Abuse Testing Product Features and Attributes
11.9.4 InTec Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.9.5 InTec Recent Developments
11.10 Orient Gene
11.10.1 Orient Gene Corporation Information
11.10.2 Orient Gene Business Overview
11.10.3 Orient Gene Drug or Substance Abuse Testing Product Features and Attributes
11.10.4 Orient Gene Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Hangzhou Biotest
11.11.1 Hangzhou Biotest Corporation Information
11.11.2 Hangzhou Biotest Business Overview
11.11.3 Hangzhou Biotest Drug or Substance Abuse Testing Product Features and Attributes
11.11.4 Hangzhou Biotest Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.11.5 Hangzhou Biotest Recent Developments
11.12 Assure Tech
11.12.1 Assure Tech Corporation Information
11.12.2 Assure Tech Business Overview
11.12.3 Assure Tech Drug or Substance Abuse Testing Product Features and Attributes
11.12.4 Assure Tech Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.12.5 Assure Tech Recent Developments
11.13 Aotai Bio
11.13.1 Aotai Bio Corporation Information
11.13.2 Aotai Bio Business Overview
11.13.3 Aotai Bio Drug or Substance Abuse Testing Product Features and Attributes
11.13.4 Aotai Bio Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.13.5 Aotai Bio Recent Developments
12 Drug or Substance Abuse TestingIndustry Chain Analysis
12.1 Drug or Substance Abuse Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Drug or Substance Abuse Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Drug or Substance Abuse Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Drug or Substance Abuse Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Drug or Substance Abuse Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Urine Testing
1.2.3 Saliva Testing
1.2.4 Blood Testing
1.2.5 Hair and Sweat Testing
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Drug or Substance Abuse Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Law Enforcement
1.3.4 Drug Treatment Center
1.3.5 Laboratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug or Substance Abuse Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Drug or Substance Abuse Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Drug or Substance Abuse Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Drug or Substance Abuse Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Urine Testing Market Size by Players
3.3.2 Saliva Testing Market Size by Players
3.3.3 Blood Testing Market Size by Players
3.3.4 Hair and Sweat Testing Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Drug or Substance Abuse Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Drug or Substance Abuse Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Drug or Substance Abuse Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Drug or Substance Abuse Testing Market Size by Type (2020-2031)
6.4 North America Drug or Substance Abuse Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Drug or Substance Abuse Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Drug or Substance Abuse Testing Market Size by Type (2020-2031)
7.4 Europe Drug or Substance Abuse Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Drug or Substance Abuse Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Drug or Substance Abuse Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Drug or Substance Abuse Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Drug or Substance Abuse Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Drug or Substance Abuse Testing Market Size by Type (2020-2031)
9.4 Central and South America Drug or Substance Abuse Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Drug or Substance Abuse Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Drug or Substance Abuse Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Drug or Substance Abuse Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Drug or Substance Abuse Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Drug or Substance Abuse Testing Product Features and Attributes
11.1.4 Abbott Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Drug or Substance Abuse Testing Revenue by Product in 2024
11.1.6 Abbott Drug or Substance Abuse Testing Revenue by Application in 2024
11.1.7 Abbott Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.1.8 Abbott Drug or Substance Abuse Testing SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Corporation Information
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Drug or Substance Abuse Testing Product Features and Attributes
11.2.4 Thermo Fisher Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Drug or Substance Abuse Testing Revenue by Product in 2024
11.2.6 Thermo Fisher Drug or Substance Abuse Testing Revenue by Application in 2024
11.2.7 Thermo Fisher Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Drug or Substance Abuse Testing SWOT Analysis
11.2.9 Thermo Fisher Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Drug or Substance Abuse Testing Product Features and Attributes
11.3.4 Roche Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.3.5 Roche Drug or Substance Abuse Testing Revenue by Product in 2024
11.3.6 Roche Drug or Substance Abuse Testing Revenue by Application in 2024
11.3.7 Roche Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.3.8 Roche Drug or Substance Abuse Testing SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Corporation Information
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Drug or Substance Abuse Testing Product Features and Attributes
11.4.4 Siemens Healthineers Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.4.5 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Product in 2024
11.4.6 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Application in 2024
11.4.7 Siemens Healthineers Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.4.8 Siemens Healthineers Drug or Substance Abuse Testing SWOT Analysis
11.4.9 Siemens Healthineers Recent Developments
11.5 Wondfo Biotech
11.5.1 Wondfo Biotech Corporation Information
11.5.2 Wondfo Biotech Business Overview
11.5.3 Wondfo Biotech Drug or Substance Abuse Testing Product Features and Attributes
11.5.4 Wondfo Biotech Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.5.5 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Product in 2024
11.5.6 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Application in 2024
11.5.7 Wondfo Biotech Drug or Substance Abuse Testing Revenue by Geographic Area in 2024
11.5.8 Wondfo Biotech Drug or Substance Abuse Testing SWOT Analysis
11.5.9 Wondfo Biotech Recent Developments
11.6 Randox
11.6.1 Randox Corporation Information
11.6.2 Randox Business Overview
11.6.3 Randox Drug or Substance Abuse Testing Product Features and Attributes
11.6.4 Randox Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.6.5 Randox Recent Developments
11.7 OraSure
11.7.1 OraSure Corporation Information
11.7.2 OraSure Business Overview
11.7.3 OraSure Drug or Substance Abuse Testing Product Features and Attributes
11.7.4 OraSure Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.7.5 OraSure Recent Developments
11.8 Draeger
11.8.1 Draeger Corporation Information
11.8.2 Draeger Business Overview
11.8.3 Draeger Drug or Substance Abuse Testing Product Features and Attributes
11.8.4 Draeger Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.8.5 Draeger Recent Developments
11.9 InTec
11.9.1 InTec Corporation Information
11.9.2 InTec Business Overview
11.9.3 InTec Drug or Substance Abuse Testing Product Features and Attributes
11.9.4 InTec Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.9.5 InTec Recent Developments
11.10 Orient Gene
11.10.1 Orient Gene Corporation Information
11.10.2 Orient Gene Business Overview
11.10.3 Orient Gene Drug or Substance Abuse Testing Product Features and Attributes
11.10.4 Orient Gene Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Hangzhou Biotest
11.11.1 Hangzhou Biotest Corporation Information
11.11.2 Hangzhou Biotest Business Overview
11.11.3 Hangzhou Biotest Drug or Substance Abuse Testing Product Features and Attributes
11.11.4 Hangzhou Biotest Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.11.5 Hangzhou Biotest Recent Developments
11.12 Assure Tech
11.12.1 Assure Tech Corporation Information
11.12.2 Assure Tech Business Overview
11.12.3 Assure Tech Drug or Substance Abuse Testing Product Features and Attributes
11.12.4 Assure Tech Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.12.5 Assure Tech Recent Developments
11.13 Aotai Bio
11.13.1 Aotai Bio Corporation Information
11.13.2 Aotai Bio Business Overview
11.13.3 Aotai Bio Drug or Substance Abuse Testing Product Features and Attributes
11.13.4 Aotai Bio Drug or Substance Abuse Testing Revenue and Gross Margin (2020-2025)
11.13.5 Aotai Bio Recent Developments
12 Drug or Substance Abuse TestingIndustry Chain Analysis
12.1 Drug or Substance Abuse Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Drug or Substance Abuse Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Drug or Substance Abuse Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Drug or Substance Abuse Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug or Substance Abuse Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug or Substance Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug or Substance Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Drug or Substance Abuse Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Drug or Substance Abuse Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Drug or Substance Abuse Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug or Substance Abuse Testing as of 2024)
Table 11. Global Drug or Substance Abuse Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Drug or Substance Abuse Testing Companies Headquarters
Table 13. Global Drug or Substance Abuse Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Drug or Substance Abuse Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Drug or Substance Abuse Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Drug or Substance Abuse Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Drug or Substance Abuse Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Drug or Substance Abuse Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 25. North America Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 27. Europe Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Drug or Substance Abuse Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Drug or Substance Abuse Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abbott Revenue Proportion by Product in 2024
Table 39. Abbott Revenue Proportion by Application in 2024
Table 40. Abbott Revenue Proportion by Geographic Area in 2024
Table 41. Abbott Drug or Substance Abuse Testing SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. Thermo Fisher Corporation Information
Table 44. Thermo Fisher Description and Major Businesses
Table 45. Thermo Fisher Product Features and Attributes
Table 46. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Drug or Substance Abuse Testing SWOT Analysis
Table 51. Thermo Fisher Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche Drug or Substance Abuse Testing SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Siemens Healthineers Corporation Information
Table 62. Siemens Healthineers Description and Major Businesses
Table 63. Siemens Healthineers Product Features and Attributes
Table 64. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Siemens Healthineers Revenue Proportion by Product in 2024
Table 66. Siemens Healthineers Revenue Proportion by Application in 2024
Table 67. Siemens Healthineers Revenue Proportion by Geographic Area in 2024
Table 68. Siemens Healthineers Drug or Substance Abuse Testing SWOT Analysis
Table 69. Siemens Healthineers Recent Developments
Table 70. Wondfo Biotech Corporation Information
Table 71. Wondfo Biotech Description and Major Businesses
Table 72. Wondfo Biotech Product Features and Attributes
Table 73. Wondfo Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Wondfo Biotech Revenue Proportion by Product in 2024
Table 75. Wondfo Biotech Revenue Proportion by Application in 2024
Table 76. Wondfo Biotech Revenue Proportion by Geographic Area in 2024
Table 77. Wondfo Biotech Drug or Substance Abuse Testing SWOT Analysis
Table 78. Wondfo Biotech Recent Developments
Table 79. Randox Corporation Information
Table 80. Randox Description and Major Businesses
Table 81. Randox Product Features and Attributes
Table 82. Randox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Randox Recent Developments
Table 84. OraSure Corporation Information
Table 85. OraSure Description and Major Businesses
Table 86. OraSure Product Features and Attributes
Table 87. OraSure Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. OraSure Recent Developments
Table 89. Draeger Corporation Information
Table 90. Draeger Description and Major Businesses
Table 91. Draeger Product Features and Attributes
Table 92. Draeger Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Draeger Recent Developments
Table 94. InTec Corporation Information
Table 95. InTec Description and Major Businesses
Table 96. InTec Product Features and Attributes
Table 97. InTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. InTec Recent Developments
Table 99. Orient Gene Corporation Information
Table 100. Orient Gene Description and Major Businesses
Table 101. Orient Gene Product Features and Attributes
Table 102. Orient Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Orient Gene Recent Developments
Table 104. Hangzhou Biotest Corporation Information
Table 105. Hangzhou Biotest Description and Major Businesses
Table 106. Hangzhou Biotest Product Features and Attributes
Table 107. Hangzhou Biotest Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Hangzhou Biotest Recent Developments
Table 109. Assure Tech Corporation Information
Table 110. Assure Tech Description and Major Businesses
Table 111. Assure Tech Product Features and Attributes
Table 112. Assure Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Assure Tech Recent Developments
Table 114. Aotai Bio Corporation Information
Table 115. Aotai Bio Description and Major Businesses
Table 116. Aotai Bio Product Features and Attributes
Table 117. Aotai Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Aotai Bio Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug or Substance Abuse Testing Product Picture
Figure 2. Global Drug or Substance Abuse Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Urine Testing Product Picture
Figure 4. Saliva Testing Product Picture
Figure 5. Blood Testing Product Picture
Figure 6. Hair and Sweat Testing Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drug or Substance Abuse Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospital
Figure 10. Law Enforcement
Figure 11. Drug Treatment Center
Figure 12. Laboratory
Figure 13. Others
Figure 14. Drug or Substance Abuse Testing Report Years Considered
Figure 15. Global Drug or Substance Abuse Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 17. Global Drug or Substance Abuse Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Drug or Substance Abuse Testing Revenue Market Share by Region (2020-2031)
Figure 19. Global Drug or Substance Abuse Testing Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Urine Testing Revenue Market Share by Player in 2024
Figure 22. Saliva Testing Revenue Market Share by Player in 2024
Figure 23. Blood Testing Revenue Market Share by Player in 2024
Figure 24. Hair and Sweat Testing Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global Drug or Substance Abuse Testing Revenue Market Share by Type (2020-2031)
Figure 27. Global Drug or Substance Abuse Testing Revenue Market Share by Application (2020-2031)
Figure 28. North America Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 30. North America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 37. Europe Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 40. France Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 42. Italy Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 43. Russia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Japan Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 51. Australia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 52. India Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 60. Central and South America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 66. South America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 69. Israel Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 72. Drug or Substance Abuse Testing Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Table 1. Global Drug or Substance Abuse Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug or Substance Abuse Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug or Substance Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug or Substance Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Drug or Substance Abuse Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Drug or Substance Abuse Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Drug or Substance Abuse Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug or Substance Abuse Testing as of 2024)
Table 11. Global Drug or Substance Abuse Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Drug or Substance Abuse Testing Companies Headquarters
Table 13. Global Drug or Substance Abuse Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Drug or Substance Abuse Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Drug or Substance Abuse Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Drug or Substance Abuse Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Drug or Substance Abuse Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Drug or Substance Abuse Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 25. North America Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 27. Europe Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Drug or Substance Abuse Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Drug or Substance Abuse Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Drug or Substance Abuse Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Drug or Substance Abuse Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abbott Revenue Proportion by Product in 2024
Table 39. Abbott Revenue Proportion by Application in 2024
Table 40. Abbott Revenue Proportion by Geographic Area in 2024
Table 41. Abbott Drug or Substance Abuse Testing SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. Thermo Fisher Corporation Information
Table 44. Thermo Fisher Description and Major Businesses
Table 45. Thermo Fisher Product Features and Attributes
Table 46. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Drug or Substance Abuse Testing SWOT Analysis
Table 51. Thermo Fisher Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche Drug or Substance Abuse Testing SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Siemens Healthineers Corporation Information
Table 62. Siemens Healthineers Description and Major Businesses
Table 63. Siemens Healthineers Product Features and Attributes
Table 64. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Siemens Healthineers Revenue Proportion by Product in 2024
Table 66. Siemens Healthineers Revenue Proportion by Application in 2024
Table 67. Siemens Healthineers Revenue Proportion by Geographic Area in 2024
Table 68. Siemens Healthineers Drug or Substance Abuse Testing SWOT Analysis
Table 69. Siemens Healthineers Recent Developments
Table 70. Wondfo Biotech Corporation Information
Table 71. Wondfo Biotech Description and Major Businesses
Table 72. Wondfo Biotech Product Features and Attributes
Table 73. Wondfo Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Wondfo Biotech Revenue Proportion by Product in 2024
Table 75. Wondfo Biotech Revenue Proportion by Application in 2024
Table 76. Wondfo Biotech Revenue Proportion by Geographic Area in 2024
Table 77. Wondfo Biotech Drug or Substance Abuse Testing SWOT Analysis
Table 78. Wondfo Biotech Recent Developments
Table 79. Randox Corporation Information
Table 80. Randox Description and Major Businesses
Table 81. Randox Product Features and Attributes
Table 82. Randox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Randox Recent Developments
Table 84. OraSure Corporation Information
Table 85. OraSure Description and Major Businesses
Table 86. OraSure Product Features and Attributes
Table 87. OraSure Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. OraSure Recent Developments
Table 89. Draeger Corporation Information
Table 90. Draeger Description and Major Businesses
Table 91. Draeger Product Features and Attributes
Table 92. Draeger Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Draeger Recent Developments
Table 94. InTec Corporation Information
Table 95. InTec Description and Major Businesses
Table 96. InTec Product Features and Attributes
Table 97. InTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. InTec Recent Developments
Table 99. Orient Gene Corporation Information
Table 100. Orient Gene Description and Major Businesses
Table 101. Orient Gene Product Features and Attributes
Table 102. Orient Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Orient Gene Recent Developments
Table 104. Hangzhou Biotest Corporation Information
Table 105. Hangzhou Biotest Description and Major Businesses
Table 106. Hangzhou Biotest Product Features and Attributes
Table 107. Hangzhou Biotest Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Hangzhou Biotest Recent Developments
Table 109. Assure Tech Corporation Information
Table 110. Assure Tech Description and Major Businesses
Table 111. Assure Tech Product Features and Attributes
Table 112. Assure Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Assure Tech Recent Developments
Table 114. Aotai Bio Corporation Information
Table 115. Aotai Bio Description and Major Businesses
Table 116. Aotai Bio Product Features and Attributes
Table 117. Aotai Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Aotai Bio Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug or Substance Abuse Testing Product Picture
Figure 2. Global Drug or Substance Abuse Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Urine Testing Product Picture
Figure 4. Saliva Testing Product Picture
Figure 5. Blood Testing Product Picture
Figure 6. Hair and Sweat Testing Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drug or Substance Abuse Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospital
Figure 10. Law Enforcement
Figure 11. Drug Treatment Center
Figure 12. Laboratory
Figure 13. Others
Figure 14. Drug or Substance Abuse Testing Report Years Considered
Figure 15. Global Drug or Substance Abuse Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 17. Global Drug or Substance Abuse Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Drug or Substance Abuse Testing Revenue Market Share by Region (2020-2031)
Figure 19. Global Drug or Substance Abuse Testing Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Urine Testing Revenue Market Share by Player in 2024
Figure 22. Saliva Testing Revenue Market Share by Player in 2024
Figure 23. Blood Testing Revenue Market Share by Player in 2024
Figure 24. Hair and Sweat Testing Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global Drug or Substance Abuse Testing Revenue Market Share by Type (2020-2031)
Figure 27. Global Drug or Substance Abuse Testing Revenue Market Share by Application (2020-2031)
Figure 28. North America Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 30. North America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 37. Europe Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 40. France Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 42. Italy Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 43. Russia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Japan Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 51. Australia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 52. India Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore Drug or Substance Abuse Testing Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 60. Central and South America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa Drug or Substance Abuse Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players Drug or Substance Abuse Testing Revenue (US$ Million) in 2024
Figure 66. South America Drug or Substance Abuse Testing Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa Drug or Substance Abuse Testing Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 69. Israel Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa Drug or Substance Abuse Testing Revenue (2020-2025) & (US$ Million)
Figure 72. Drug or Substance Abuse Testing Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232